Troubled Maryland plant told to toss part of the J&J vaccine ingredient it manufactured

In late March, quality control checks revealed cross-contamination at Emergent BioSolutions, the Baltimore facility which was producing substances to be used in vaccine doses from both J&J and AstraZeneca. Stephen Zenner/Getty Images